(Q85216785)

English

UGT1A11/28 and 1/6 genotypes have no effects on the efficacy and toxicity of FOLFIRI in Japanese patients with advanced colorectal cancer

scientific article published on October 19, 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20957480%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

UGT1A1*1/*28 and *1/*6 genotypes have no effects on the efficacy and toxicity of FOLFIRI in Japanese patients with advanced colorectal cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20957480%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

colorectal cancer

1 reference

based on heuristic

inferred from title

colorectal carcinoma

1 reference

based on heuristic

inferred from title

genetic polymorphism

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20957480

5 August 2024

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20957480%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

17

object named as

Shigehira Saji

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20957480%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

15

object named as

Yuichi Ando

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20957480

5 August 2024

author name string

Yu Sunakawa

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20957480%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Wataru Ichikawa

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20957480%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Ken-Ichi Fujita

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20957480%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Fumio Nagashima

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20957480%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Hiroo Ishida

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20957480%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Keishi Yamashita

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20957480%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Keiko Mizuno

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20957480%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Keisuke Miwa

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20957480%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Kaori Kawara

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20957480%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Yuko Akiyama

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20957480%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Wataru Yamamoto

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20957480%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Toshimichi Miya

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20957480%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Masaru Narabayashi

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20957480%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Takashi Hirose

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20957480%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Yasutsuna Sasaki

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20957480%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20957480

5 August 2024

publication date

19 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20957480%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

full work available at URL

http://link.springer.com/content/pdf/10.1007/s00280-010-1485-8.pdf

Portable Document Format

1 reference

10.1007/S00280-010-1485-8

https://api.crossref.org/works/10.1007/S00280-010-1485-8

5 August 2024

http://link.springer.com/article/10.1007/s00280-010-1485-8/fulltext.html

1 reference

10.1007/S00280-010-1485-8

https://api.crossref.org/works/10.1007/S00280-010-1485-8

5 August 2024

http://link.springer.com/content/pdf/10.1007/s00280-010-1485-8

1 reference

10.1007/S00280-010-1485-8

https://api.crossref.org/works/10.1007/S00280-010-1485-8

5 August 2024

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20957480%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

68

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20957480%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20957480%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

279-284

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20957480%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan

2

1 reference

10.1007/S00280-010-1485-8

https://api.crossref.org/works/10.1007/S00280-010-1485-8

5 August 2024

Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?

4

1 reference

10.1007/S00280-010-1485-8

https://api.crossref.org/works/10.1007/S00280-010-1485-8

5 August 2024

Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38).

5

1 reference

10.1007/S00280-010-1485-8

https://api.crossref.org/works/10.1007/S00280-010-1485-8

5 August 2024

Genetic testing for UGT1A1*28 and *6 in Japanese patients who receive irinotecan chemotherapy.

6

1 reference

10.1007/S00280-010-1485-8

https://api.crossref.org/works/10.1007/S00280-010-1485-8

5 August 2024

Irinotecan pharmacokinetics/pharmacodynamics and UGT1A genetic polymorphisms in Japanese: roles of UGT1A1*6 and *28

7

1 reference

10.1007/S00280-010-1485-8

https://api.crossref.org/works/10.1007/S00280-010-1485-8

5 August 2024

Comprehensive analysis of UGT1A polymorphisms predictive for pharmacokinetics and treatment outcome in patients with non-small-cell lung cancer treated with irinotecan and cisplatin

8

1 reference

10.1007/S00280-010-1485-8

https://api.crossref.org/works/10.1007/S00280-010-1485-8

5 August 2024

The Role of UGT1A1*28 Polymorphism in the Pharmacodynamics and Pharmacokinetics of Irinotecan in Patients With Metastatic Colorectal Cancer

9

1 reference

10.1007/S00280-010-1485-8

https://api.crossref.org/works/10.1007/S00280-010-1485-8

5 August 2024

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

10

1 reference

10.1007/S00280-010-1485-8

https://api.crossref.org/works/10.1007/S00280-010-1485-8

5 August 2024

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

11

1 reference

10.1007/S00280-010-1485-8

https://api.crossref.org/works/10.1007/S00280-010-1485-8

5 August 2024

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

12

1 reference

10.1007/S00280-010-1485-8

https://api.crossref.org/works/10.1007/S00280-010-1485-8

5 August 2024

Genetic linkage of UGT1A7 and UGT1A9 polymorphisms to UGT1A1*6 is associated with reduced activity for SN-38 in Japanese patients with cancer

13

1 reference

10.1007/S00280-010-1485-8

https://api.crossref.org/works/10.1007/S00280-010-1485-8

5 August 2024

UGT1A1 gene variations and irinotecan treatment in patients with metastatic colorectal cancer

14

1 reference

10.1007/S00280-010-1485-8

https://api.crossref.org/works/10.1007/S00280-010-1485-8

5 August 2024

Predictive role of the UGT1A1, UGT1A7, and UGT1A9 genetic variants and their haplotypes on the outcome of metastatic colorectal cancer patients treated with fluorouracil, leucovorin, and irinotecan.

15

1 reference

10.1007/S00280-010-1485-8

https://api.crossref.org/works/10.1007/S00280-010-1485-8

5 August 2024

Pharmacogenetic impact of polymorphisms in the coding region of the UGT1A1 gene on SN-38 glucuronidation in Japanese patients with cancer.

16

1 reference

10.1007/S00280-010-1485-8

https://api.crossref.org/works/10.1007/S00280-010-1485-8

5 August 2024

UGT1A1*28 genotype and irinotecan-induced neutropenia: dose matters

17

1 reference

10.1007/S00280-010-1485-8

https://api.crossref.org/works/10.1007/S00280-010-1485-8

5 August 2024

Re: UGT1A1*28 genotype and irinotecan-induced neutropenia: dose matters.

18

1 reference

10.1007/S00280-010-1485-8

https://api.crossref.org/works/10.1007/S00280-010-1485-8

5 August 2024

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q85216785&oldid=2221722776"